Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Lisinopril Market Growth 2022-2028

  • LP 4760098
  • 129 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Lisinopril will have significant change from previous year. According to our (LP Information) latest study, the global Lisinopril market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Lisinopril market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Lisinopril market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Lisinopril market, reaching US$ million by the year 2028. As for the Europe Lisinopril landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Lisinopril players cover Actavis Elizabeth, Apotex, Aurobindo Pharma, and Ivax Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Lisinopril market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

2.5mg

5mg

10mg

20mg

30mg

40mg

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital

Drug Store

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Actavis Elizabeth

Apotex

Aurobindo Pharma

Ivax Pharmaceuticals

Lek Pharmaceuticals

Lupin

Mylan Pharmaceuticals

Ranbaxy Pharmaceuticals

Novartis

Teva Pharmaceuticals

Vintage Pharmaceuticals

Watson Laboratories

West Ward Pharmaceutical

Wockhardt

Merck Research Laboratories

Astrazeneca

Alvogen

Hikma

Prinston

Accord Hlthcare

CASI Pharms

Invagen Pharms

SUN Pharm

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Lisinopril Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Lisinopril by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Lisinopril by Country/Region, 2017, 2022 & 2028

2.2 Lisinopril Segment by Type

2.2.1 2.5mg

2.2.2 5mg

2.2.3 10mg

2.2.4 20mg

2.2.5 30mg

2.2.6 40mg

2.3 Lisinopril Sales by Type

2.3.1 Global Lisinopril Sales Market Share by Type (2017-2022)

2.3.2 Global Lisinopril Revenue and Market Share by Type (2017-2022)

2.3.3 Global Lisinopril Sale Price by Type (2017-2022)

2.4 Lisinopril Segment by Application

2.4.1 Hospital

2.4.2 Drug Store

2.5 Lisinopril Sales by Application

2.5.1 Global Lisinopril Sale Market Share by Application (2017-2022)

2.5.2 Global Lisinopril Revenue and Market Share by Application (2017-2022)

2.5.3 Global Lisinopril Sale Price by Application (2017-2022)

3 Global Lisinopril by Company

3.1 Global Lisinopril Breakdown Data by Company

3.1.1 Global Lisinopril Annual Sales by Company (2020-2022)

3.1.2 Global Lisinopril Sales Market Share by Company (2020-2022)

3.2 Global Lisinopril Annual Revenue by Company (2020-2022)

3.2.1 Global Lisinopril Revenue by Company (2020-2022)

3.2.2 Global Lisinopril Revenue Market Share by Company (2020-2022)

3.3 Global Lisinopril Sale Price by Company

3.4 Key Manufacturers Lisinopril Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Lisinopril Product Location Distribution

3.4.2 Players Lisinopril Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Lisinopril by Geographic Region

4.1 World Historic Lisinopril Market Size by Geographic Region (2017-2022)

4.1.1 Global Lisinopril Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Lisinopril Annual Revenue by Geographic Region

4.2 World Historic Lisinopril Market Size by Country/Region (2017-2022)

4.2.1 Global Lisinopril Annual Sales by Country/Region (2017-2022)

4.2.2 Global Lisinopril Annual Revenue by Country/Region

4.3 Americas Lisinopril Sales Growth

4.4 APAC Lisinopril Sales Growth

4.5 Europe Lisinopril Sales Growth

4.6 Middle East & Africa Lisinopril Sales Growth

5 Americas

5.1 Americas Lisinopril Sales by Country

5.1.1 Americas Lisinopril Sales by Country (2017-2022)

5.1.2 Americas Lisinopril Revenue by Country (2017-2022)

5.2 Americas Lisinopril Sales by Type

5.3 Americas Lisinopril Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Lisinopril Sales by Region

6.1.1 APAC Lisinopril Sales by Region (2017-2022)

6.1.2 APAC Lisinopril Revenue by Region (2017-2022)

6.2 APAC Lisinopril Sales by Type

6.3 APAC Lisinopril Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Lisinopril by Country

7.1.1 Europe Lisinopril Sales by Country (2017-2022)

7.1.2 Europe Lisinopril Revenue by Country (2017-2022)

7.2 Europe Lisinopril Sales by Type

7.3 Europe Lisinopril Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Lisinopril by Country

8.1.1 Middle East & Africa Lisinopril Sales by Country (2017-2022)

8.1.2 Middle East & Africa Lisinopril Revenue by Country (2017-2022)

8.2 Middle East & Africa Lisinopril Sales by Type

8.3 Middle East & Africa Lisinopril Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Lisinopril

10.3 Manufacturing Process Analysis of Lisinopril

10.4 Industry Chain Structure of Lisinopril

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Lisinopril Distributors

11.3 Lisinopril Customer

12 World Forecast Review for Lisinopril by Geographic Region

12.1 Global Lisinopril Market Size Forecast by Region

12.1.1 Global Lisinopril Forecast by Region (2023-2028)

12.1.2 Global Lisinopril Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Lisinopril Forecast by Type

12.7 Global Lisinopril Forecast by Application

13 Key Players Analysis

13.1 Actavis Elizabeth

13.1.1 Actavis Elizabeth Company Information

13.1.2 Actavis Elizabeth Lisinopril Product Offered

13.1.3 Actavis Elizabeth Lisinopril Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Actavis Elizabeth Main Business Overview

13.1.5 Actavis Elizabeth Latest Developments

13.2 Apotex

13.2.1 Apotex Company Information

13.2.2 Apotex Lisinopril Product Offered

13.2.3 Apotex Lisinopril Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Apotex Main Business Overview

13.2.5 Apotex Latest Developments

13.3 Aurobindo Pharma

13.3.1 Aurobindo Pharma Company Information

13.3.2 Aurobindo Pharma Lisinopril Product Offered

13.3.3 Aurobindo Pharma Lisinopril Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Aurobindo Pharma Main Business Overview

13.3.5 Aurobindo Pharma Latest Developments

13.4 Ivax Pharmaceuticals

13.4.1 Ivax Pharmaceuticals Company Information

13.4.2 Ivax Pharmaceuticals Lisinopril Product Offered

13.4.3 Ivax Pharmaceuticals Lisinopril Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Ivax Pharmaceuticals Main Business Overview

13.4.5 Ivax Pharmaceuticals Latest Developments

13.5 Lek Pharmaceuticals

13.5.1 Lek Pharmaceuticals Company Information

13.5.2 Lek Pharmaceuticals Lisinopril Product Offered

13.5.3 Lek Pharmaceuticals Lisinopril Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Lek Pharmaceuticals Main Business Overview

13.5.5 Lek Pharmaceuticals Latest Developments

13.6 Lupin

13.6.1 Lupin Company Information

13.6.2 Lupin Lisinopril Product Offered

13.6.3 Lupin Lisinopril Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Lupin Main Business Overview

13.6.5 Lupin Latest Developments

13.7 Mylan Pharmaceuticals

13.7.1 Mylan Pharmaceuticals Company Information

13.7.2 Mylan Pharmaceuticals Lisinopril Product Offered

13.7.3 Mylan Pharmaceuticals Lisinopril Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Mylan Pharmaceuticals Main Business Overview

13.7.5 Mylan Pharmaceuticals Latest Developments

13.8 Ranbaxy Pharmaceuticals

13.8.1 Ranbaxy Pharmaceuticals Company Information

13.8.2 Ranbaxy Pharmaceuticals Lisinopril Product Offered

13.8.3 Ranbaxy Pharmaceuticals Lisinopril Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Ranbaxy Pharmaceuticals Main Business Overview

13.8.5 Ranbaxy Pharmaceuticals Latest Developments

13.9 Novartis

13.9.1 Novartis Company Information

13.9.2 Novartis Lisinopril Product Offered

13.9.3 Novartis Lisinopril Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Novartis Main Business Overview

13.9.5 Novartis Latest Developments

13.10 Teva Pharmaceuticals

13.10.1 Teva Pharmaceuticals Company Information

13.10.2 Teva Pharmaceuticals Lisinopril Product Offered

13.10.3 Teva Pharmaceuticals Lisinopril Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Teva Pharmaceuticals Main Business Overview

13.10.5 Teva Pharmaceuticals Latest Developments

13.11 Vintage Pharmaceuticals

13.11.1 Vintage Pharmaceuticals Company Information

13.11.2 Vintage Pharmaceuticals Lisinopril Product Offered

13.11.3 Vintage Pharmaceuticals Lisinopril Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Vintage Pharmaceuticals Main Business Overview

13.11.5 Vintage Pharmaceuticals Latest Developments

13.12 Watson Laboratories

13.12.1 Watson Laboratories Company Information

13.12.2 Watson Laboratories Lisinopril Product Offered

13.12.3 Watson Laboratories Lisinopril Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Watson Laboratories Main Business Overview

13.12.5 Watson Laboratories Latest Developments

13.13 West Ward Pharmaceutical

13.13.1 West Ward Pharmaceutical Company Information

13.13.2 West Ward Pharmaceutical Lisinopril Product Offered

13.13.3 West Ward Pharmaceutical Lisinopril Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 West Ward Pharmaceutical Main Business Overview

13.13.5 West Ward Pharmaceutical Latest Developments

13.14 Wockhardt

13.14.1 Wockhardt Company Information

13.14.2 Wockhardt Lisinopril Product Offered

13.14.3 Wockhardt Lisinopril Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Wockhardt Main Business Overview

13.14.5 Wockhardt Latest Developments

13.15 Merck Research Laboratories

13.15.1 Merck Research Laboratories Company Information

13.15.2 Merck Research Laboratories Lisinopril Product Offered

13.15.3 Merck Research Laboratories Lisinopril Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Merck Research Laboratories Main Business Overview

13.15.5 Merck Research Laboratories Latest Developments

13.16 Astrazeneca

13.16.1 Astrazeneca Company Information

13.16.2 Astrazeneca Lisinopril Product Offered

13.16.3 Astrazeneca Lisinopril Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Astrazeneca Main Business Overview

13.16.5 Astrazeneca Latest Developments

13.17 Alvogen

13.17.1 Alvogen Company Information

13.17.2 Alvogen Lisinopril Product Offered

13.17.3 Alvogen Lisinopril Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Alvogen Main Business Overview

13.17.5 Alvogen Latest Developments

13.18 Hikma

13.18.1 Hikma Company Information

13.18.2 Hikma Lisinopril Product Offered

13.18.3 Hikma Lisinopril Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Hikma Main Business Overview

13.18.5 Hikma Latest Developments

13.19 Prinston

13.19.1 Prinston Company Information

13.19.2 Prinston Lisinopril Product Offered

13.19.3 Prinston Lisinopril Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Prinston Main Business Overview

13.19.5 Prinston Latest Developments

13.20 Accord Hlthcare

13.20.1 Accord Hlthcare Company Information

13.20.2 Accord Hlthcare Lisinopril Product Offered

13.20.3 Accord Hlthcare Lisinopril Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Accord Hlthcare Main Business Overview

13.20.5 Accord Hlthcare Latest Developments

13.21 CASI Pharms

13.21.1 CASI Pharms Company Information

13.21.2 CASI Pharms Lisinopril Product Offered

13.21.3 CASI Pharms Lisinopril Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 CASI Pharms Main Business Overview

13.21.5 CASI Pharms Latest Developments

13.22 Invagen Pharms

13.22.1 Invagen Pharms Company Information

13.22.2 Invagen Pharms Lisinopril Product Offered

13.22.3 Invagen Pharms Lisinopril Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 Invagen Pharms Main Business Overview

13.22.5 Invagen Pharms Latest Developments

13.23 SUN Pharm

13.23.1 SUN Pharm Company Information

13.23.2 SUN Pharm Lisinopril Product Offered

13.23.3 SUN Pharm Lisinopril Sales, Revenue, Price and Gross Margin (2020-2022)

13.23.4 SUN Pharm Main Business Overview

13.23.5 SUN Pharm Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Lisinopril Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Lisinopril Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 2.5mg

Table 4. Major Players of 5mg

Table 5. Major Players of 10mg

Table 6. Major Players of 20mg

Table 7. Major Players of 30mg

Table 8. Major Players of 40mg

Table 9. Global Lisinopril Sales by Type (2017-2022) & (K Units)

Table 10. Global Lisinopril Sales Market Share by Type (2017-2022)

Table 11. Global Lisinopril Revenue by Type (2017-2022) & ($ million)

Table 12. Global Lisinopril Revenue Market Share by Type (2017-2022)

Table 13. Global Lisinopril Sale Price by Type (2017-2022) & (US$/Unit)

Table 14. Global Lisinopril Sales by Application (2017-2022) & (K Units)

Table 15. Global Lisinopril Sales Market Share by Application (2017-2022)

Table 16. Global Lisinopril Revenue by Application (2017-2022)

Table 17. Global Lisinopril Revenue Market Share by Application (2017-2022)

Table 18. Global Lisinopril Sale Price by Application (2017-2022) & (US$/Unit)

Table 19. Global Lisinopril Sales by Company (2020-2022) & (K Units)

Table 20. Global Lisinopril Sales Market Share by Company (2020-2022)

Table 21. Global Lisinopril Revenue by Company (2020-2022) ($ Millions)

Table 22. Global Lisinopril Revenue Market Share by Company (2020-2022)

Table 23. Global Lisinopril Sale Price by Company (2020-2022) & (US$/Unit)

Table 24. Key Manufacturers Lisinopril Producing Area Distribution and Sales Area

Table 25. Players Lisinopril Products Offered

Table 26. Lisinopril Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global Lisinopril Sales by Geographic Region (2017-2022) & (K Units)

Table 30. Global Lisinopril Sales Market Share Geographic Region (2017-2022)

Table 31. Global Lisinopril Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global Lisinopril Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global Lisinopril Sales by Country/Region (2017-2022) & (K Units)

Table 34. Global Lisinopril Sales Market Share by Country/Region (2017-2022)

Table 35. Global Lisinopril Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global Lisinopril Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas Lisinopril Sales by Country (2017-2022) & (K Units)

Table 38. Americas Lisinopril Sales Market Share by Country (2017-2022)

Table 39. Americas Lisinopril Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas Lisinopril Revenue Market Share by Country (2017-2022)

Table 41. Americas Lisinopril Sales by Type (2017-2022) & (K Units)

Table 42. Americas Lisinopril Sales Market Share by Type (2017-2022)

Table 43. Americas Lisinopril Sales by Application (2017-2022) & (K Units)

Table 44. Americas Lisinopril Sales Market Share by Application (2017-2022)

Table 45. APAC Lisinopril Sales by Region (2017-2022) & (K Units)

Table 46. APAC Lisinopril Sales Market Share by Region (2017-2022)

Table 47. APAC Lisinopril Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC Lisinopril Revenue Market Share by Region (2017-2022)

Table 49. APAC Lisinopril Sales by Type (2017-2022) & (K Units)

Table 50. APAC Lisinopril Sales Market Share by Type (2017-2022)

Table 51. APAC Lisinopril Sales by Application (2017-2022) & (K Units)

Table 52. APAC Lisinopril Sales Market Share by Application (2017-2022)

Table 53. Europe Lisinopril Sales by Country (2017-2022) & (K Units)

Table 54. Europe Lisinopril Sales Market Share by Country (2017-2022)

Table 55. Europe Lisinopril Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe Lisinopril Revenue Market Share by Country (2017-2022)

Table 57. Europe Lisinopril Sales by Type (2017-2022) & (K Units)

Table 58. Europe Lisinopril Sales Market Share by Type (2017-2022)

Table 59. Europe Lisinopril Sales by Application (2017-2022) & (K Units)

Table 60. Europe Lisinopril Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa Lisinopril Sales by Country (2017-2022) & (K Units)

Table 62. Middle East & Africa Lisinopril Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa Lisinopril Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa Lisinopril Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa Lisinopril Sales by Type (2017-2022) & (K Units)

Table 66. Middle East & Africa Lisinopril Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa Lisinopril Sales by Application (2017-2022) & (K Units)

Table 68. Middle East & Africa Lisinopril Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of Lisinopril

Table 70. Key Market Challenges & Risks of Lisinopril

Table 71. Key Industry Trends of Lisinopril

Table 72. Lisinopril Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. Lisinopril Distributors List

Table 75. Lisinopril Customer List

Table 76. Global Lisinopril Sales Forecast by Region (2023-2028) & (K Units)

Table 77. Global Lisinopril Sales Market Forecast by Region

Table 78. Global Lisinopril Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global Lisinopril Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas Lisinopril Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Americas Lisinopril Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC Lisinopril Sales Forecast by Region (2023-2028) & (K Units)

Table 83. APAC Lisinopril Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe Lisinopril Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Europe Lisinopril Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa Lisinopril Sales Forecast by Country (2023-2028) & (K Units)

Table 87. Middle East & Africa Lisinopril Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global Lisinopril Sales Forecast by Type (2023-2028) & (K Units)

Table 89. Global Lisinopril Sales Market Share Forecast by Type (2023-2028)

Table 90. Global Lisinopril Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global Lisinopril Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global Lisinopril Sales Forecast by Application (2023-2028) & (K Units)

Table 93. Global Lisinopril Sales Market Share Forecast by Application (2023-2028)

Table 94. Global Lisinopril Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global Lisinopril Revenue Market Share Forecast by Application (2023-2028)

Table 96. Actavis Elizabeth Basic Information, Lisinopril Manufacturing Base, Sales Area and Its Competitors

Table 97. Actavis Elizabeth Lisinopril Product Offered

Table 98. Actavis Elizabeth Lisinopril Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 99. Actavis Elizabeth Main Business

Table 100. Actavis Elizabeth Latest Developments

Table 101. Apotex Basic Information, Lisinopril Manufacturing Base, Sales Area and Its Competitors

Table 102. Apotex Lisinopril Product Offered

Table 103. Apotex Lisinopril Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 104. Apotex Main Business

Table 105. Apotex Latest Developments

Table 106. Aurobindo Pharma Basic Information, Lisinopril Manufacturing Base, Sales Area and Its Competitors

Table 107. Aurobindo Pharma Lisinopril Product Offered

Table 108. Aurobindo Pharma Lisinopril Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 109. Aurobindo Pharma Main Business

Table 110. Aurobindo Pharma Latest Developments

Table 111. Ivax Pharmaceuticals Basic Information, Lisinopril Manufacturing Base, Sales Area and Its Competitors

Table 112. Ivax Pharmaceuticals Lisinopril Product Offered

Table 113. Ivax Pharmaceuticals Lisinopril Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 114. Ivax Pharmaceuticals Main Business

Table 115. Ivax Pharmaceuticals Latest Developments

Table 116. Lek Pharmaceuticals Basic Information, Lisinopril Manufacturing Base, Sales Area and Its Competitors

Table 117. Lek Pharmaceuticals Lisinopril Product Offered

Table 118. Lek Pharmaceuticals Lisinopril Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 119. Lek Pharmaceuticals Main Business

Table 120. Lek Pharmaceuticals Latest Developments

Table 121. Lupin Basic Information, Lisinopril Manufacturing Base, Sales Area and Its Competitors

Table 122. Lupin Lisinopril Product Offered

Table 123. Lupin Lisinopril Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 124. Lupin Main Business

Table 125. Lupin Latest Developments

Table 126. Mylan Pharmaceuticals Basic Information, Lisinopril Manufacturing Base, Sales Area and Its Competitors

Table 127. Mylan Pharmaceuticals Lisinopril Product Offered

Table 128. Mylan Pharmaceuticals Lisinopril Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 129. Mylan Pharmaceuticals Main Business

Table 130. Mylan Pharmaceuticals Latest Developments

Table 131. Ranbaxy Pharmaceuticals Basic Information, Lisinopril Manufacturing Base, Sales Area and Its Competitors

Table 132. Ranbaxy Pharmaceuticals Lisinopril Product Offered

Table 133. Ranbaxy Pharmaceuticals Lisinopril Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 134. Ranbaxy Pharmaceuticals Main Business

Table 135. Ranbaxy Pharmaceuticals Latest Developments

Table 136. Novartis Basic Information, Lisinopril Manufacturing Base, Sales Area and Its Competitors

Table 137. Novartis Lisinopril Product Offered

Table 138. Novartis Lisinopril Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 139. Novartis Main Business

Table 140. Novartis Latest Developments

Table 141. Teva Pharmaceuticals Basic Information, Lisinopril Manufacturing Base, Sales Area and Its Competitors

Table 142. Teva Pharmaceuticals Lisinopril Product Offered

Table 143. Teva Pharmaceuticals Lisinopril Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 144. Teva Pharmaceuticals Main Business

Table 145. Teva Pharmaceuticals Latest Developments

Table 146. Vintage Pharmaceuticals Basic Information, Lisinopril Manufacturing Base, Sales Area and Its Competitors

Table 147. Vintage Pharmaceuticals Lisinopril Product Offered

Table 148. Vintage Pharmaceuticals Lisinopril Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 149. Vintage Pharmaceuticals Main Business

Table 150. Vintage Pharmaceuticals Latest Developments

Table 151. Watson Laboratories Basic Information, Lisinopril Manufacturing Base, Sales Area and Its Competitors

Table 152. Watson Laboratories Lisinopril Product Offered

Table 153. Watson Laboratories Lisinopril Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 154. Watson Laboratories Main Business

Table 155. Watson Laboratories Latest Developments

Table 156. West Ward Pharmaceutical Basic Information, Lisinopril Manufacturing Base, Sales Area and Its Competitors

Table 157. West Ward Pharmaceutical Lisinopril Product Offered

Table 158. West Ward Pharmaceutical Lisinopril Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 159. West Ward Pharmaceutical Main Business

Table 160. West Ward Pharmaceutical Latest Developments

Table 161. Wockhardt Basic Information, Lisinopril Manufacturing Base, Sales Area and Its Competitors

Table 162. Wockhardt Lisinopril Product Offered

Table 163. Wockhardt Lisinopril Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 164. Wockhardt Main Business

Table 165. Wockhardt Latest Developments

Table 166. Merck Research Laboratories Basic Information, Lisinopril Manufacturing Base, Sales Area and Its Competitors

Table 167. Merck Research Laboratories Lisinopril Product Offered

Table 168. Merck Research Laboratories Lisinopril Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 169. Merck Research Laboratories Main Business

Table 170. Merck Research Laboratories Latest Developments

Table 171. Astrazeneca Basic Information, Lisinopril Manufacturing Base, Sales Area and Its Competitors

Table 172. Astrazeneca Lisinopril Product Offered

Table 173. Astrazeneca Lisinopril Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 174. Astrazeneca Main Business

Table 175. Astrazeneca Latest Developments

Table 176. Alvogen Basic Information, Lisinopril Manufacturing Base, Sales Area and Its Competitors

Table 177. Alvogen Lisinopril Product Offered

Table 178. Alvogen Lisinopril Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 179. Alvogen Main Business

Table 180. Alvogen Latest Developments

Table 181. Hikma Basic Information, Lisinopril Manufacturing Base, Sales Area and Its Competitors

Table 182. Hikma Lisinopril Product Offered

Table 183. Hikma Lisinopril Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 184. Hikma Main Business

Table 185. Hikma Latest Developments

Table 186. Prinston Basic Information, Lisinopril Manufacturing Base, Sales Area and Its Competitors

Table 187. Prinston Lisinopril Product Offered

Table 188. Prinston Lisinopril Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 189. Prinston Main Business

Table 190. Prinston Latest Developments

Table 191. Accord Hlthcare Basic Information, Lisinopril Manufacturing Base, Sales Area and Its Competitors

Table 192. Accord Hlthcare Lisinopril Product Offered

Table 193. Accord Hlthcare Lisinopril Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 194. Accord Hlthcare Main Business

Table 195. Accord Hlthcare Latest Developments

Table 196. CASI Pharms Basic Information, Lisinopril Manufacturing Base, Sales Area and Its Competitors

Table 197. CASI Pharms Lisinopril Product Offered

Table 198. CASI Pharms Lisinopril Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 199. CASI Pharms Main Business

Table 200. CASI Pharms Latest Developments

Table 201. Invagen Pharms Basic Information, Lisinopril Manufacturing Base, Sales Area and Its Competitors

Table 202. Invagen Pharms Lisinopril Product Offered

Table 203. Invagen Pharms Lisinopril Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 204. Invagen Pharms Main Business

Table 205. Invagen Pharms Latest Developments

Table 206. SUN Pharm Basic Information, Lisinopril Manufacturing Base, Sales Area and Its Competitors

Table 207. SUN Pharm Lisinopril Product Offered

Table 208. SUN Pharm Lisinopril Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 209. SUN Pharm Main Business

Table 210. SUN Pharm Latest Developments

List of Figures

Figure 1. Picture of Lisinopril

Figure 2. Lisinopril Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Lisinopril Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Lisinopril Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Lisinopril Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 2.5mg

Figure 10. Product Picture of 5mg

Figure 11. Product Picture of 10mg

Figure 12. Product Picture of 20mg

Figure 13. Product Picture of 30mg

Figure 14. Product Picture of 40mg

Figure 15. Global Lisinopril Sales Market Share by Type in 2021

Figure 16. Global Lisinopril Revenue Market Share by Type (2017-2022)

Figure 17. Lisinopril Consumed in Hospital

Figure 18. Global Lisinopril Market: Hospital (2017-2022) & (K Units)

Figure 19. Lisinopril Consumed in Drug Store

Figure 20. Global Lisinopril Market: Drug Store (2017-2022) & (K Units)

Figure 21. Global Lisinopril Sales Market Share by Application (2017-2022)

Figure 22. Global Lisinopril Revenue Market Share by Application in 2021

Figure 23. Lisinopril Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Lisinopril Revenue Market Share by Company in 2021

Figure 25. Global Lisinopril Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Lisinopril Revenue Market Share by Geographic Region in 2021

Figure 27. Global Lisinopril Sales Market Share by Region (2017-2022)

Figure 28. Global Lisinopril Revenue Market Share by Country/Region in 2021

Figure 29. Americas Lisinopril Sales 2017-2022 (K Units)

Figure 30. Americas Lisinopril Revenue 2017-2022 ($ Millions)

Figure 31. APAC Lisinopril Sales 2017-2022 (K Units)

Figure 32. APAC Lisinopril Revenue 2017-2022 ($ Millions)

Figure 33. Europe Lisinopril Sales 2017-2022 (K Units)

Figure 34. Europe Lisinopril Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Lisinopril Sales 2017-2022 (K Units)

Figure 36. Middle East & Africa Lisinopril Revenue 2017-2022 ($ Millions)

Figure 37. Americas Lisinopril Sales Market Share by Country in 2021

Figure 38. Americas Lisinopril Revenue Market Share by Country in 2021

Figure 39. United States Lisinopril Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Lisinopril Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Lisinopril Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Lisinopril Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Lisinopril Sales Market Share by Region in 2021

Figure 44. APAC Lisinopril Revenue Market Share by Regions in 2021

Figure 45. China Lisinopril Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Lisinopril Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Lisinopril Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Lisinopril Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Lisinopril Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Lisinopril Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Lisinopril Sales Market Share by Country in 2021

Figure 52. Europe Lisinopril Revenue Market Share by Country in 2021

Figure 53. Germany Lisinopril Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Lisinopril Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Lisinopril Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Lisinopril Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Lisinopril Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Lisinopril Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Lisinopril Revenue Market Share by Country in 2021

Figure 60. Egypt Lisinopril Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Lisinopril Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Lisinopril Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Lisinopril Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Lisinopril Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Lisinopril in 2021

Figure 66. Manufacturing Process Analysis of Lisinopril

Figure 67. Industry Chain Structure of Lisinopril

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390